171 related articles for article (PubMed ID: 9371292)
1. Recent advances in biological and therapeutic aspects of myeloproliferative disorders.
Mancini M; Diverio D; Alimena G; Mandelli F
Curr Opin Hematol; 1994 Jul; 1(4):261-7. PubMed ID: 9371292
[TBL] [Abstract][Full Text] [Related]
2. Current world literature.
Curr Opin Hematol; 2011 Mar; 18(2):124-31. PubMed ID: 21307671
[No Abstract] [Full Text] [Related]
3. Myelodysplastic and myeloproliferative disorders in children.
Hasle H
Curr Opin Pediatr; 2007 Feb; 19(1):1-8. PubMed ID: 17224655
[TBL] [Abstract][Full Text] [Related]
4. [Molecular biologic study in chronic myelogenous leukemia and its related disorders].
Ohyashiki JH; Ohyashiki K; Toyama K
Rinsho Ketsueki; 1988 Jul; 29(7):1010-7. PubMed ID: 3184468
[No Abstract] [Full Text] [Related]
5. Chromosome abnormalities in the myeloproliferative disorders.
Dewald GW; Wright PI
Semin Oncol; 1995 Aug; 22(4):341-54. PubMed ID: 7638632
[No Abstract] [Full Text] [Related]
6. [bcr rearrangement in variant Ph1-positive chronic myelocytic leukemia and unclassified myeloproliferative disorders].
Sekito N; Takahashi I
Rinsho Ketsueki; 1988 Jul; 29(7):1018-24. PubMed ID: 3184469
[No Abstract] [Full Text] [Related]
7. Chronic myeloproliferative disorder with t(8;22)(p11;q11) can mime clonal cytogenetic evolution of authentic chronic myelogeneous leukemia.
Richebourg S; Theisen O; Plantier I; Parry A; Soenen-Cornu V; Lepelley P; Preudhomme C; Renneville A; Laï JL; Roche-Lestienne C
Genes Chromosomes Cancer; 2008 Oct; 47(10):915-8. PubMed ID: 18615682
[No Abstract] [Full Text] [Related]
8. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
Tefferi A
Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
[TBL] [Abstract][Full Text] [Related]
9. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
Roumier C; Daudignon A; Soenen V; Dupriez B; Wetterwald M; Lai JL; Cosson A; Fenaux P; Preudhomme C
Haematologica; 1999 Dec; 84(12):1075-80. PubMed ID: 10586207
[TBL] [Abstract][Full Text] [Related]
10. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes].
Bock O
Verh Dtsch Ges Pathol; 2007; 91():140-53. PubMed ID: 18314608
[TBL] [Abstract][Full Text] [Related]
11. Recent advancements in the treatment of chronic myelogenous leukemia.
O'Dwyer ME; Mauro MJ; Druker BJ
Annu Rev Med; 2002; 53():369-81. PubMed ID: 11818480
[TBL] [Abstract][Full Text] [Related]
12. Recurrent Cytogenetic Abnormalities in Myeloproliferative Neoplasms and Chronic Myeloid Leukemia.
Swansbury J
Methods Mol Biol; 2017; 1541():247-256. PubMed ID: 27910028
[TBL] [Abstract][Full Text] [Related]
13. Myeloproliferative neoplasms: new translational therapies.
Mascarenhas J; Hoffman R
Mt Sinai J Med; 2010; 77(6):667-83. PubMed ID: 21105128
[TBL] [Abstract][Full Text] [Related]
14. Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
Haferlach C; Rieder H; Lillington DM; Dastugue N; Hagemeijer A; Harbott J; Stilgenbauer S; Knuutila S; Johansson B; Fonatsch C
Genes Chromosomes Cancer; 2007 May; 46(5):494-9. PubMed ID: 17311250
[TBL] [Abstract][Full Text] [Related]
15. Molecular diagnosis of myeloproliferative neoplasms.
Patnaik MM; Tefferi A
Expert Rev Mol Diagn; 2009 Jul; 9(5):481-92. PubMed ID: 19580432
[TBL] [Abstract][Full Text] [Related]
16. Is there an entity of chemically induced BCR-ABL-positive chronic myelogenous leukemia?
Lichtman MA
Oncologist; 2008 Jun; 13(6):645-54. PubMed ID: 18586919
[TBL] [Abstract][Full Text] [Related]
17. A chronic myelogenous leukemia-like myeloproliferative disorder accompanied by T-cell lymphoblastic lymphoma with chromosome translocation t(8;13)(p11;q12): a Japanese case.
Matsumoto K; Morita K; Takada S; Sakura T; Shiozaki H; Murakami H; Miyawaki S
Int J Hematol; 1999 Dec; 70(4):278-82. PubMed ID: 10643154
[TBL] [Abstract][Full Text] [Related]
18. Chronic myeloproliferative disorders--introduction.
Skoda R; Prchal JT
Semin Hematol; 2005 Oct; 42(4):181-3. PubMed ID: 16210031
[No Abstract] [Full Text] [Related]
19. [Chronic granulocytic leukemia (Ph+): among yesterday's myeloproliferative syndromes, today's chronic myeloid leukemias, and tomorrow's mature-element monocellular myelopathies].
Sánchez Fayos J; Prieto E; Chica Gullón E
Sangre (Barc); 1998 Apr; 43(2):121-6. PubMed ID: 9656773
[No Abstract] [Full Text] [Related]
20. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
